Rezolute Inc.

11/30/2021 | Press release | Archived content

Attenuation of Insulin Action by an Allosteric Insulin Receptor Antibody in Healthy Volunteers

Rezolute Inc. published this content on November 30, 2021, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 11, 2025 at 09:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]